Twenty three elderly people died in Norway, shortly after getting the Pfizer mRNA-based coronavirus vaccine at the end of December last year. The nation initiated a vaccination programme, with vaccination first available to the very oldest people and residents of nursing homes.
All the deaths have occurred in frail, and all the patients are over 80 years old and some of them are over 90, Norwegian media reported.
Though there is no certain connection between these deaths and the vaccine, the Norwegian Medicines Agency on its website asserted that 13 of the 23 people who died have shown common side effects of mRNA vaccines such as diarrhea, nausea, and fever.
Meanwhile, Pfizer has now gone to temporarily reduce its vaccine supply in Europe following the concerns raised with the deaths in Norway.
All reported deaths will be thoroughly evaluated by the Norwegian Medicines Agency (NOMA) to determine if these incidents are related to the vaccine. The Norwegian government will also consider adjusting their vaccination instructions to take the patients’ health into more consideration.
Doctors in Norway have been asked to conduct more thorough evaluations of very frail elderly patients in line to receive the Pfizer-BioNTech vaccine, following the reported deaths, the British Medical Journal (BMJ) reported late Friday.
“It may be a coincidence, but we aren’t sure,” Steinar Madsen, medical director of the Norwegian Medicines Agency (NOMA), told the BMJ.
Chinese publication Global Times first broke the story, saying that health experts in the country have called on Norway and other countries to suspend the use of Pfizer’s mRNA-based Covid-19 vaccine after the 23 deaths were reported post-vaccination.
With the deaths of 23 elderly, experts have said, “Doctors must now carefully consider who should be vaccinated.